Tauriga Sciences Inc. (OTC PINK: TAUG), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer, Mr. Seth M. Shaw ("Mr. Shaw"), has made an additional personal investment into the Company totaling $55,000 USD at this time. This personal investment was once again structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent"), for a total of 44,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). Including the personal investment disclosed last week ($95,000 USD on June 15, 2017), Mr. Shaw has now invested a total of $150,000 USD into the Company at this price of $0.00125 per share; for a total of 120,000,000 shares. The Company will utiliz e this infusion of working capital for general and administrative purposes; these 44,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpract ice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD.